Improving cancer treatment with cyclotron produced radionuclides
This report describes the author's continuing long term goal of promoting nuclear medicine applications by improving the scientific basis for tumor diagnosis treatment and treatment follow-up based on the use of cyclotron produced radiotracers in oncology. The program has 3 interactive components: Radiochemistry /Cyclotron; Pharmacology; and Immunology. An essential strategy is as follows: novel radionuclides and radiotracers developed in the Radiochemistry/Cyclotron section under the DOE grant during the 1989--1992 grant period, will be employed in the Pharmacology and Immunology sections of the DOE grant during the 1992--1995 grant period. The development of novel radionuclides and tracers is of course useful in and of itself, but their utility is greatly enhanced by the interaction with the immunology and pharmacology components of the program.
- Research Organization:
- Sloan-Kettering Inst. for Cancer Research, New York, NY (United States)
- Sponsoring Organization:
- DOE; USDOE, Washington, DC (United States)
- DOE Contract Number:
- FG02-86ER60407
- OSTI ID:
- 7262962
- Report Number(s):
- DOE/ER/60407-7; ON: DE92040310
- Country of Publication:
- United States
- Language:
- English
Similar Records
Improving cancer treatment with cyclotron produced radionuclides. Comprehensive progress report, February 1, 1990--January 31, 1993
Improving cancer treatment with cyclotron produced radionuclides. Comprehensive progress report, February 1, 1992--July 15, 1995
Improving cancer treatment with cyclotron produced radionuclides. Progress report
Technical Report
·
Tue Aug 04 00:00:00 EDT 1992
·
OSTI ID:10177676
Improving cancer treatment with cyclotron produced radionuclides. Comprehensive progress report, February 1, 1992--July 15, 1995
Technical Report
·
Mon Jul 17 00:00:00 EDT 1995
·
OSTI ID:171316
Improving cancer treatment with cyclotron produced radionuclides. Progress report
Technical Report
·
Sun Oct 31 23:00:00 EST 1993
·
OSTI ID:10118877
Related Subjects
550604* -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ACCELERATORS
AZINES
BETA DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
CHEMISTRY
COMPUTERIZED TOMOGRAPHY
CYCLIC ACCELERATORS
CYCLOTRONS
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DIAGNOSTIC USES
DOCUMENT TYPES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
EMISSION COMPUTED TOMOGRAPHY
FLUORINE 18
FLUORINE ISOTOPES
GALLIUM 66
GALLIUM ISOTOPES
HETEROCYCLIC COMPOUNDS
HOURS LIVING RADIOISOTOPES
HYDROXY COMPOUNDS
INTERMEDIATE MASS NUCLEI
IODINE 124
IODINE ISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
LIGHT NUCLEI
MEDICINE
NANOSEC LIVING RADIOISOTOPES
NUCLEAR MEDICINE
NUCLEI
NUCLEOSIDES
NUCLEOTIDES
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
POSITRON COMPUTED TOMOGRAPHY
PROGRESS REPORT
PYRIMIDINES
RADIOCHEMISTRY
RADIOISOTOPES
RADIOPHARMACEUTICALS
RIBOSIDES
TOMOGRAPHY
URACILS
URIDINE
USES
62 RADIOLOGY AND NUCLEAR MEDICINE
ACCELERATORS
AZINES
BETA DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
CHEMISTRY
COMPUTERIZED TOMOGRAPHY
CYCLIC ACCELERATORS
CYCLOTRONS
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DIAGNOSTIC USES
DOCUMENT TYPES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
EMISSION COMPUTED TOMOGRAPHY
FLUORINE 18
FLUORINE ISOTOPES
GALLIUM 66
GALLIUM ISOTOPES
HETEROCYCLIC COMPOUNDS
HOURS LIVING RADIOISOTOPES
HYDROXY COMPOUNDS
INTERMEDIATE MASS NUCLEI
IODINE 124
IODINE ISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
LIGHT NUCLEI
MEDICINE
NANOSEC LIVING RADIOISOTOPES
NUCLEAR MEDICINE
NUCLEI
NUCLEOSIDES
NUCLEOTIDES
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
POSITRON COMPUTED TOMOGRAPHY
PROGRESS REPORT
PYRIMIDINES
RADIOCHEMISTRY
RADIOISOTOPES
RADIOPHARMACEUTICALS
RIBOSIDES
TOMOGRAPHY
URACILS
URIDINE
USES